Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$1.94 -0.02 (-1.02%)
As of: Oct 20, 2026 · 3:58 PM EDT

Xtl Biopharmaceuticals (XTLB) Receivables - Net (2009 - 2025)

Updated

Xtl Biopharmaceuticals' Receivables - Net came in at $99,000 for the quarter ended Dec 31, 2025, unchanged from $99,000 a year earlier.

Analysis

Xtl Biopharmaceuticals (XTLB) Receivables - Net (2009 - 2025) Analysis & Trends

Going back to the quarter ended Mar 31, 2009, Xtl Biopharmaceuticals' Receivables - Net data covers 26 quarters.

  • Going back by year, Receivables - Net was $99,000 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Xtl Biopharmaceuticals 18.55 Mn 15.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 99,000.00
Dec 31, 2024 99,000.00
Sep 30, 2024 140,000.00
Sep 30, 2014 134,000.00
Jun 30, 2014 144,000.00
Mar 31, 2014 115,000.00
Dec 31, 2013 126,000.00
Sep 30, 2013 106,000.00
Jun 30, 2013 97,000.00
Mar 31, 2013 99,000.00
Dec 31, 2012 111,674.85
Sep 30, 2012 50,000.00
Jun 30, 2012 96,000.00
Mar 31, 2012 72,000.00
Dec 31, 2011 209,942.73
Sep 30, 2011 49,000.00
Jun 30, 2011 59,000.00
Mar 31, 2011 92,000.00
Dec 31, 2010 110,000.00
Sep 30, 2010 19,000.00
API Access

Xtl Biopharmaceuticals Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=XTLB&period=max&api_key=YOUR_API_KEY